Test Price
2,800 AED✅ Home Collection Available
APOA5 Gene Hyperchylomicronemia Type 5 Genetic Test in UAE | 2800 AED
Executive Summary & Core Metrics
This advanced genetic test sequences the entire APOA5 gene using Next‑Generation Sequencing (NGS) to identify pathogenic variants causing hyperchylomicronemia type 5, a severe form of hypertriglyceridemia linked to life‑threatening pancreatitis. The analysis achieves 99.9% diagnostic sensitivity and is performed in an ISO 9001:2015 accredited laboratory (Cert: INT/EGQ/2509DA/3139).
- Accuracy Guarantee: 99.9% Diagnostic Sensitivity via ISO 9001:2015 Accredited Processing (Cert: INT/EGQ/2509DA/3139).
- Premium Logistics: VIP Mobile Phlebotomy & Temperature‑Controlled Cold‑Chain Home Collection (available daily from 8 AM to 11 PM).
- Clinical Guidance: Telephonic Post‑Test Clinical Guidance in result interpretation with our DHA‑licensed genetics specialist.
- Insurance: Direct Billing Verification via WhatsApp at +971 54 548 8731.
Test Overview & Methodology
The APOA5 NGS Test provides full gene coverage to detect both known and novel variants. A mandatory pre‑test genetic counseling session is required to construct a detailed pedigree chart and collect clinical history, lipid panel results, and prior genetic testing reports. Acceptable sample types include whole blood (2–5 mL in EDTA tube), extracted DNA, or one drop of blood on an FTA card. Fasting is not required, but lipid‑lowering medications must be documented.
| Feature | Our Test – APOA5 NGS | Closest Alternative (Targeted Genotyping) |
|---|---|---|
| Precision | Full gene coverage, detects novel & known variants | Limited to predefined hotspots; may miss rare mutations |
| Methodology | Next‑Generation Sequencing (NGS) with LC‑MS/MS verification | PCR‑based fragment analysis or Sanger sequencing of few exons |
| Turnaround Time | 3 – 4 Weeks | 2 – 6 Weeks (often outsourced) |
Physician Insight & Safety Protocols
“I recommend this test for individuals with unexplained severe hypertriglyceridemia or recurrent pancreatitis and a family history. Results must be interpreted alongside lipid profiles and clinical evaluation. Genetic counseling is imperative to understand implications for family members.”
— Lina Osama Zaki Quteineh, Consultant Medical Genetics, DHA Registration ID: 9294403
⚠️ Medication Advisory
Do not discontinue prescribed lipid‑lowering medication without consulting your doctor.
Exclusion Criteria & ER Red Flags
- Exclusion Criteria: Individuals who have not completed a pre‑test genetic counseling session; inability to provide informed consent; minors without legal guardian consent.
- ER Red Flags (seek immediate care): Severe acute abdominal pain suggestive of pancreatitis; confusion or lethargy accompanied by markedly elevated triglycerides (>1000 mg/dL); signs of hyperviscosity syndrome.
Patient FAQ & Clinical Guidance
1. What is the purpose of the APOA5 gene test?
This test identifies pathogenic variants in the APOA5 gene causing hyperchylomicronemia type 5, enabling targeted prevention of acute pancreatitis and cardiovascular risks. Clinical management may include strict dietary fat restriction, fibrates, and monitoring.
2. How should I prepare for the blood draw, and will diet affect the result?
Fasting is not mandatory for DNA analysis, but you must inform the phlebotomist of all medications and supplements you are taking. Genetic testing detects inherited mutations, not temporary dietary influences.
3. What happens after the results are reported?
A board‑certified clinical geneticist will provide a detailed interpretive report, and a telephonic consultation is included to explain findings and implications. All data is protected under UAE PDPL and Federal Law No. 2 of 2019.
UAE Regulatory & Data Privacy Adherence
This test is performed in full compliance with UAE healthcare regulations. Data security and patient privacy are governed by Federal Decree‑Law No. 45 of 2021 on Personal Data Protection (PDPL) and Federal Law No. 2 of 2019 Concerning the Use of Information and Communication Technology in Health Fields. Clinical safety and patient consent follow Federal Decree‑Law No. 4 of 2016 on Medical Liability.
Clinical & Logistical Metadata
| Test Name | APOA5 Gene Hyperchylomicronemia Type 5 Genetic Test |
| Price (AED) | 2,800 |
| Turnaround Time | 3 – 4 Weeks |
| Sample Type / Matrix | Peripheral whole blood (EDTA tube), extracted DNA, or FTA card |
| Methodology Used | Next‑Generation Sequencing (NGS) with LC‑MS/MS verification |
| ICD-10-CM Code | E78.3 (Hyperchylomicronemia) |
| LOINC Code | 81293-3 (APOA5 gene mutation analysis) |
| DHA Facility License & Address | License: 1143 | Premises 105, Floor 1, Building 33, Dubai Healthcare City, Dubai, UAE | DNA Labs UAE |
دعم ثنائي اللغة متاح
التحقق من التغطية التأمينية
Check Insurance Coverage Instantly
Stop the guesswork. Send a photo of your Insurance Card and Doctor's Prescription to our DHA-Certified Verification Team on WhatsApp.
توقف عن التخمين. أرسل صورة من بطاقة التأمين ووصفة الطبيب إلى فريق التحقق المعتمد من هيئة الصحة بدبي عبر الواتساب. احصل على تحديث الحالة في دقائق.
Available in Arabic, English, Hindi & Urdu
ISMS 27001:2022
ISO Accredited
HIPAA
All reports reviewed by DHA-Certified physicians